Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × tocilizumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 10 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Lymphoma, Follicular 2 Lymphoma 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Respiratory Tract Infections 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

tocilizumab 1 aldesleukin 1 X-Rays 1 Thoracoscopy 1 Thoracentesis 1 Pleurodesis 1 Pharmaceutical Preparations 1 Metformin 1 Interleukin-2 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡